ライフサイエンスコーパス: Mason-Pfizer monkey virus

1 e release by a distantly related retrovirus, Mason-Pfizer monkey virus.

2 otein that interacts with the Gag protein of Mason-Pfizer monkey virus.

3 targeting and retention signal CTRS found in Mason-Pfizer monkey virus and that FV Gag has the inhere

4 ntracellular capsid transport and release of Mason-Pfizer monkey virus are dependent on myristylation

5 bly and release of murine leukemia virus and Mason-Pfizer monkey virus are insensitive to TSG-5'.

6 g of Gag protein shells-immature capsids--of Mason-Pfizer monkey virus assembled in Escherichia coli

7 A transcriptional enhancer element from the Mason-Pfizer monkey virus can override the silencing and

8 wever, the constitutive transport element of Mason-Pfizer monkey virus can substitute for RRE and Rev

9 Tap interacts directly with the Mason-Pfizer monkey virus constitutive transport element

10 nclusion of cis-acting elements, such as the Mason-Pfizer monkey virus constitutive transport element

11 the nuclear export of mRNAs that contain the Mason-Pfizer monkey virus constitutive transport element

12 sm by either Rev/Rev response element or the Mason-Pfizer monkey virus constitutive transport element

13 trast, DeltaCAN had no significant affect on Mason-Pfizer monkey virus constitutive transport element

14 The transmembrane protein of Mason-Pfizer monkey virus contains two heptad repeats th

15 RNA comprised almost entirely of the CTE of Mason-Pfizer monkey virus (CTE RNA) is exported efficien

16 ssion of unspliced RNA containing either the Mason-Pfizer monkey virus-CTE or the recently discovered

17 plasma membrane assembly, PPPY L domain) and Mason-Pfizer monkey virus (cytoplasmic assembly, PPPY L

18 itutive transport element (CTE) derived from Mason-Pfizer monkey virus for expression of the viral pr

19 Unlike most retroviruses, the Mason-Pfizer monkey virus Gag polyproteins assemble into

20 SRV-2 and Mason-Pfizer monkey virus have highly homologous element

21 ent is different from that seen in HIV-1 and Mason-Pfizer monkey virus, illustrating further structur

22 scribe a unique experimental system in which Mason-Pfizer monkey virus immature capsids are removed f

23 Mason-Pfizer monkey virus immature capsids selected from

24 avian sarcoma virus IN, rather than HIV-1 or Mason-Pfizer monkey virus IN, were substituted into the

25 4 and pp16 proteins of the type D retrovirus Mason-Pfizer monkey virus (M-PMV) are phosphoproteins th

26 an immunodeficiency virus type 1 (HIV-1) and Mason-Pfizer monkey virus (M-PMV) but not Moloney murine

27 Mason-Pfizer monkey virus (M-PMV) capsids that have asse

28 Mason-Pfizer monkey virus (M-PMV) encodes a transmembran

29 Mason-Pfizer monkey virus (M-PMV) encodes a transmembran

30 High Five cells expressing wild-type Mason-Pfizer monkey virus (M-PMV) Gag precursors accumul

31 The Mason-Pfizer monkey virus (M-PMV) Gag protein possesses

32 ag-derived protein of the related retrovirus Mason-Pfizer monkey virus (M-PMV) has previously been re

33 Mason-Pfizer monkey virus (M-PMV) is a prototypical beta

34 The Mason-Pfizer monkey virus (M-PMV) is the prototype of th

35 1) as a cellular factor regulating HIV-1 and Mason-Pfizer monkey virus (M-PMV) particle release.

36 lock glycoprotein incorporation into budding Mason-Pfizer monkey virus (M-PMV) particles and abrogate

37 the structures and membrane affinity of the Mason-Pfizer monkey virus (M-PMV) wild-type MA with its

38 We sought to determine whether or not Mason-Pfizer monkey virus (M-PMV), a prototype betaretro

39 psids of the prototypical type D retrovirus, Mason-Pfizer monkey virus (M-PMV), can assemble in a cel

40 thin the assembled Gag lattices of HIV-1 and Mason-Pfizer monkey virus (M-PMV), the C-terminal domain

41 Mason-Pfizer monkey virus (M-PMV), the prototype type D

42 Mason-Pfizer monkey virus (M-PMV), the prototypical type

43 ing either a Rev response element (RRE) or a Mason-Pfizer monkey virus (MPMV) constitutive transport

44 onal regulatory element (PRE)-containing and Mason-Pfizer monkey virus (MPMV) constitutive transport

45 and env expression vectors that contain the Mason-Pfizer monkey virus (MPMV) constitutive transport

46 ow that the genome of the simpler retrovirus Mason-Pfizer monkey virus (MPMV) contains an element tha

47 me that the 5' long terminal repeat (LTR) of Mason-Pfizer monkey virus (MPMV) facilitates Rev/Rev-res

48 Here, we demonstrate that Mason-Pfizer monkey virus (MPMV) is resistant to inhibit

49 s well as a nonlentiviral retrovirus such as Mason-Pfizer monkey virus (MPMV), and vice versa.

50 the constitutive transport element (CTE) of Mason-Pfizer monkey virus (MPMV), or the pre-mRNA proces

51 an association of KIF-4 with Gag proteins of Mason-Pfizer monkey virus (MPMV), simian immunodeficienc

52 he constitutive transport element (CTE) from Mason-Pfizer monkey virus (MPMV).

53 ype 1 (HIV-1), Rous sarcoma virus (RSV), and Mason-Pfizer monkey virus (MPMV)] and discuss structural

54 d recently in the distal zinc knuckle of the Mason-Pfizer monkey virus nucleocapsid protein.

55 For example, Mason-Pfizer monkey virus overcomes cellular restriction

56 clear export of RNA transcripts derived from Mason-Pfizer monkey virus that contain the constitutive

57 In Mason-Pfizer monkey virus, the required RNA sequence ele

58 separates the CA and NC domains, whereas in Mason-Pfizer monkey virus, this region is densely packed

59 roviruses (HIV-1, murine leukemia virus, and Mason-Pfizer monkey virus), two hepadnaviruses (hepatiti

60 SCRT-I was required for efficient release of Mason-Pfizer monkey virus, which buds primarily by using